Age Sways Europe’s Bloodstream Infection Rate Projections

The incidence of bloodstream infections may differ significantly across populations. Failure to account for these factors may lead to inaccurate projections.

Written byAndrea Lius, PhD
| 3 min read
A futuristic-looking map of Europe, representing how the recent study projects future trends of bloodstream infection incidence in Europe.
Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Every year, antibiotic-resistant infections contribute to millions of deaths around the world. Age and sex can influence people’s susceptibility to these infections, but researchers do not know the extent to which these variations affect current or future trends of antibiotic-resistant infection incidence. This knowledge gap may confound their ability to intervene.

Gwenan Knight, a systems biologist at the London School of Hygiene and Tropical Medicine, wanted to better understand how demographic factors affect the rate of antibiotic-resistant infections across different populations. In a recent study, Knight and her colleagues performed computational modeling to project the incidence of bloodstream infections, including those caused by antibiotic-resistant pathogens, in Europe between 2022 and 2050.1 Their predictions revealed an increase in infection rates among adults between ages 60 and 89, but the rates seemed to stabilize, or even decline, among younger populations. The researchers also observed that this trend was more prominent in males than females, revealing a sex-based distinction. Their findings, published in PLoS Medicine, indicate that demographic factors significantly affect the incidence of antibiotic-resistant infections.

Continue reading below...

Like this story? Sign up for FREE Immunology updates:

Latest science news storiesTopic-tailored resources and eventsCustomized newsletter content
Subscribe

“Our study shows that the future burden of drug-resistant infections won’t be uniform,” said Knight in a statement. “Age and sex are still rarely considered in antimicrobial resistance projections, yet they make a real difference to who is most affected.”

Two multi-colored line graphs show the projected incidence of bloodstream infections in European females (left) and males (right) between 2022 and 2050. Each line represents an age group (15-year intervals, described in the figure legend).

European adults aged 60 to 89 are especially vulnerable to bloodstream infections. Though this trend is observable in both sexes, cases are expected to rise more steeply in males.

The Scientist, modified from infographic by Anthony Lewis (www.anthony-lewis.com), PLoS

In a large, global-scale study, researchers previously predicted that older adults are likely at a higher risk of mortality due to antibiotic-resistant infections.2 However, they projected antimicrobial resistance-related deaths, not the incidence of infections. Furthermore, while the team considered variations in age, region, and types of bacteria, they did not assess sex differences.

In the present study, Knight and her team focused only on Europe and employed a much simpler statistical model for their projections than the previous study. They analyzed publicly available data on the susceptibility of eight bacterial pathogens that commonly cause bloodstream infections to antibiotics from different European countries between 2010 and 2019. They then used these data to project the prevalence of bloodstream infections, including those caused by antibiotic-resistance microbes, through 2050. To evaluate the effects of demographic factors such as age and sex on the incidence of antibiotic-resistant infections, the researchers compared models that took these variables into consideration to those that did not.

When the researchers did not account for age and sex, they observed that nearly half of the bacteria-antibiotic combinations showed a downward trend over time. On the other hand, models that considered the demographic factors revealed that adults aged between 60 and 89 were especially vulnerable. Furthermore, within this age group, cases were expected to increase much more steeply in males than in females. These results suggest that without considering demographic factors, researchers may severely overlook the vulnerability of certain populations and thus propose unsuitable interventions.

“This is a fantastic step forward in understanding the way that age and sex will influence the burden of drug-resistant infections in different European countries in the coming years,” said Catrin Moore, an infectious disease researcher at City St. George’s University of London and a coauthor of the study. “This [study] will help us design intervention studies focusing on the populations most at risk in the future,” she added.

Related Topics

Meet the Author

  • Image of Andrea Lius.

    Andrea Lius is an intern at The Scientist. She earned her PhD in pharmacology from the University of Washington. Besides science, she also enjoys writing short-form creative nonfiction.

    View Full Profile
Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
Image of a woman with her hands across her stomach. She has a look of discomfort on her face. There is a blown up image of her stomach next to her and it has colorful butterflies and gut bacteria all swarming within the gut.
November 2025, Issue 1

Why Do We Feel Butterflies in the Stomach?

These fluttering sensations are the brain’s reaction to certain emotions, which can be amplified or soothed by the gut’s own “bugs".

View this Issue
Olga Anczukow and Ryan Englander discuss how transcriptome splicing affects immune system function in lung cancer.

Long-Read RNA Sequencing Reveals a Regulatory Role for Splicing in Immunotherapy Responses

Pacific Biosciences logo
Research Roundtable: The Evolving World of Spatial Biology

Research Roundtable: The Evolving World of Spatial Biology

Conceptual cartoon image of gene editing technology

Exploring the State of the Art in Gene Editing Techniques

Bio-Rad
Conceptual image of a doctor holding a brain puzzle, representing Alzheimer's disease diagnosis.

Simplifying Early Alzheimer’s Disease Diagnosis with Blood Testing

fujirebio logo

Products

Labvantage Logo

LabVantage Solutions Awarded $22.3 Million U.S Customs and Border Protection Contract to Deliver Next-Generation Forensic LIMS

The Scientist Placeholder Image

Evosep Unveils Open Innovation Initiative to Expand Standardization in Proteomics

OGT logo

OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS Panel